Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy

Esophageal squamous cell carcinoma (ESCC) accounts for 90% of all cases of esophageal cancers worldwide. Although neoadjuvant chemotherapy (NACT-ESCC) improves the survival of ESCC patients, the five-year survival rate of these patients is dismal. The tumor microenvironment (TME) and tumor heterogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhencong, Huang, Yiwei, Hu, Zhengyang, Zhao, Mengnan, Bian, Yunyi, Chen, Zongwei, Zheng, Yuansheng, Bi, Guoshu, Pang, Yanrui, Zhan, Cheng, Lin, Zongwu, Guo, Weigang, Wang, Qun, Tan, Lijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546051/
https://www.ncbi.nlm.nih.gov/pubmed/34697289
http://dx.doi.org/10.1038/s41389-021-00359-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546051/
https://www.ncbi.nlm.nih.gov/pubmed/34697289
http://dx.doi.org/10.1038/s41389-021-00359-2

Ejemplares similares